Home5VB • FRA
add
Nykode Therapeutics ASA
Previous close
€0.10
Day range
€0.11 - €0.11
Year range
€0.10 - €1.45
Avg Volume
977.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 137.00K | -86.52% |
Operating expense | 7.68M | -53.79% |
Net income | -1.44M | 90.34% |
Net profit margin | -1.05K | 28.34% |
Earnings per share | 0.00 | 100.00% |
EBITDA | -7.36M | 52.27% |
Effective tax rate | 58.70% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 106.23M | -27.88% |
Total assets | 146.61M | -23.60% |
Total liabilities | 12.67M | -61.81% |
Total equity | 133.95M | — |
Shares outstanding | 326.55M | — |
Price to book | 0.25 | — |
Return on assets | -12.57% | — |
Return on capital | -13.62% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.44M | 90.34% |
Cash from operations | -10.36M | 25.70% |
Cash from investing | 342.00K | 344.16% |
Cash from financing | -341.00K | -10.00% |
Net change in cash | -9.16M | 40.13% |
Free cash flow | -8.19M | 24.18% |
About
Founded
2006
Website
Employees
75
